HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katherine Thornton Selected Research

vandetanib (ZD6474)

7/2012Vandetanib for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease: U.S. Food and Drug Administration drug approval summary.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katherine Thornton Research Topics

Disease

11Neoplasms (Cancer)
04/2022 - 02/2007
8Sarcoma (Soft Tissue Sarcoma)
01/2022 - 06/2008
4Hemangiosarcoma (Angiosarcoma)
01/2022 - 01/2020
1Disease Progression
01/2022
1Anemia
01/2022
1Diarrhea
01/2022
1Epistaxis (Nosebleed)
01/2022
1Fatigue
01/2022
1Headache (Headaches)
01/2022
1Hypertension (High Blood Pressure)
01/2022
1Nausea
01/2022
1Vomiting
01/2022
1Leiomyosarcoma
01/2020
1Liposarcoma
01/2020
1Synovial Sarcoma (Synovioma)
01/2020
1Myxoid Liposarcoma
01/2020
1Cardiotoxicity
01/2020
1Turcot syndrome
01/2019
1medullary Thyroid cancer
07/2012
1Sudden Death
07/2012
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2009
1Virus Diseases (Viral Diseases)
09/2008
1Colorectal Neoplasms (Colorectal Cancer)
09/2008
1Infections
10/2007
1Bacterial Infections (Bacterial Infection)
10/2007
1Venous Thromboembolism
02/2007
1Pulmonary Embolism
02/2007
1Postthrombotic Syndrome
02/2007
1Acute Kidney Injury (Acute Renal Failure)
09/2006

Drug/Important Bio-Agent (IBA)

3Pharmaceutical PreparationsIBA
01/2020 - 07/2012
2Immune Checkpoint InhibitorsIBA
01/2022 - 01/2019
2pazopanibFDA Link
01/2022 - 01/2020
2Biological ProductsIBA
01/2022 - 06/2008
1carotuximabIBA
01/2022
1NivolumabIBA
01/2022
1Interleukin-2 (IL2)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1bempegaldesleukinIBA
01/2022
1AnthracyclinesIBA
01/2020
1PM 01183IBA
01/2020
1GemcitabineFDA Link
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2019
1TabletsIBA
07/2012
1vandetanib (ZD6474)IBA
07/2012
1Tamsulosin (Flomax)FDA LinkGeneric
01/2009
1Finasteride (Propecia)FDA LinkGeneric
01/2009
1Circulating Tumor DNAIBA
09/2008
1DNA (Deoxyribonucleic Acid)IBA
09/2008
1Cell-Free Nucleic AcidsIBA
09/2008
1Cytotoxins (Cytolysins)IBA
10/2007
1Lipase (Acid Lipase)FDA Link
10/2007
1Liposomes (Liposome)IBA
10/2007
1fialuridineIBA
10/2007
1RadiopharmaceuticalsIBA
10/2007
1Heparin (Liquaemin)FDA LinkGeneric
02/2007
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
02/2007

Therapy/Procedure

8Therapeutics
01/2022 - 02/2007
5Drug Therapy (Chemotherapy)
01/2022 - 09/2006
2Brachytherapy
04/2021 - 01/2020
1Music Therapy
04/2022
1Aftercare (After-Treatment)
04/2022
1Immunotherapy
01/2019
1Neoadjuvant Therapy
04/2017
1Vena Cava Filters (Inferior Vena Cava Filter)
02/2007
1Compression Stockings
02/2007